A national case study of virtual care visits for Parkinson’s disease (RACE-PD): Interim assessment of participant and investigator experiences
Objective: RACE-PD is a case series that aims to assess the feasibility and utility of a national program providing individuals with Parkinson's disease (PD) a…Differential effects of tango, treadmill, and stretching interventions on gait in people with Parkinson’s disease
Objective: To compare how three exercise interventions differentially impact gait in people with Parkinson's disease (PD) during different gait tasks. Background: Gait impairments are common…Adenosine A2A receptor antagonist istradefylline might have efficacy to fatigue and depression in some patients of Parkinson’s disease
Objective: To evaluate the efficacy of istradefylline, a selective adenosine A2A receptor antagonist, for fatigue and depression in Parkinson's disease (PD) patients. Background: Istradefylline is…Switching double-blind opicapone, entacapone or placebo to open-label opicapone: Efficacy results of the 1-year extension of study BIPARK I
Objective: Evaluate the efficacy of opicapone (OPC) in Parkinson's disease (PD) patients with motor fluctuations enrolled in the 1-year extension of study BIPARK I. Background:…Speech and voice range profile in patients with Parkinson’s disease with deep brain stimulation: Preliminary data
Objective: To assess the use of Voice Range Profile(VRP) and Speech Range Profile(SRP) in the evaluation of patients with on and off Deep brain stimulation(DBS).…Evaluation of impulse control disorders in fluctuating Parkinson’s disease patients under opicapone treatment
Objective: Evaluate the impulse control disorders reported as adverse events in phase III studies with opicapone (OPC) in fluctuating Parkinson's disease patients. Background: Impulse control…Can treadmill training facilitate the dual-task gait in Parkinson’s disease?
Objective: Investigate the effects of a single session of treadmill gait training combined with cognitive tasks on dual-task gait in Parkinson's disease. Background: The loss…Randomised trial comparing dopamine agonist, MAOB inhibitor and COMT inhibitor as adjuvant therapy in later Parkinson’s disease (PD)
Objective: The PD MED trial aimed to determine which class of drug provides the best patient-rated quality of life (QoL) when used as adjuvant therapy…Differential clinical outcomes in unifocal vs. multifocal premotor rTMS for Parkinson’s disease: A randomized trial
Objective: To compare changes in clinical outcomes after weekly low-frequency (LF) repetitive transcranial magnetic stimulation (rTMS) sessions over one vs. two pre-motor cortex (preMC) areas…The application of mobile health technology to increase physical activity in persons with Parkinson’s disease
Objective: To investigate the safety, acceptability and preliminary evidence of efficacy of a mobile health (mhealth) mediated home-based exercise program to increase physical activity in…
- « Previous Page
- 1
- …
- 109
- 110
- 111
- 112
- 113
- …
- 207
- Next Page »